The Traders Cafe with Zak Mir

Zak Mir is joined by regulars Albert Arthur, Phil Carroll and Kevin Hornsby for more stock market banter. Their guest is Gabriele Cerrone, Executive Chairman Tiziana Life Sciences (TILS) and Non Executive Chairman Okyo Pharma (OKYO)

Zak Mir is joined by regulars Albert Arthur, Phil Carroll and Kevin Hornsby for more stock market banter. Their guest this week is Melissa Sturgess, CEO Ananda Developments (ANA)

Minutes:

17s Phil’s week

1m 13s Bounce plays

2m 12s Hurricane Energy (HUR)

3m 17s Amigo (AMGO)

4m 40s Zak to Phil: HUR and AMGO and falling knives

6m 26s Phil’s free tip: negotiated trades

7m 57s Zak’s bungee jump

8m 30m Albert’s 10 baggers

9m 10s Kevin on Remote Monitored Systems (RMS)

9m 25s Albert on Seagate (SCGL)

10m 13s Phil on the mind of the average investor

11m 02s Introduction to Melissa Sturgess CEO Ananda Developments (ANA)

12m 02s Melissa on Ananda

13m 30s the Home Office letter

13m 55s stabilising Cannabis strains

14m 30s Zak to Melissa: is the show on the road?

15m 40s 6,000 medical Cannabis patients

15m 52s Phil asks about Ananda’s partnership

17m 15s Phil asks growing location?

18m 15s Melissa talks genetics and plant stability

19m 04s Zak asks about UK climate

20m 10s Melissa on being carbon neutral

20m 49s Zak asks are we in a Cannabis bubble? 

21m 47s Zak asks is this just a legalisation play?

24m 02s Zak asks whether people in pain should not just be allowed to smoke a joint?

26m 14m Melissa reminiscent of David Lenigas

27m 07s Melissa’s business background

28m 35s Zak on the applying a mining sector skill set in the medical Cannabis space.

30m 02s Albert asks regarding plant growth

32m 24s Kevin asks how long to get the all clear, and what is the financial likelihood regarding per plant?

35m 41s Kevin on read across with CBD / Hemp

36m 07s Melissa on creating a premium product

38m 52s Melissa on the Cannabis wellness effect

40m 13s Kevin asks regards whether Ananda is the first with a license?

43m 04s Zak asks how big Ananda could be?

43m 24s Phil on performance related equity issue

44m 00s Phil on concert parties

45m 11s Melissa on being in Ananda shares from the start

46m 03s Phil on being a CBD fan

46m 55m Goodbye to Melissa

47m 44s Kevin on being Ringo

48m 33s Zak on editing

49m 15s Zak on being avoided by Melissa for 3 years

50m 10s Albert’s week

50m 25s Portfolio compression

52m 00s Albert at the garden centre

53m 30s Albert on topping and tailing 

54m 18s Albert on the Bitcoin crash and being 4-6 weeks from a Covid stocks ramp

54m 55s Deepverge (DVRG), Futura Medical (FUM), Synairgen (SNG), Scancell (SCLP), MyHealthChecked (MHC)

55m 45s Kevin on Zoetic (ZOE)

Zak Mir talks to George Frangeskides, Executive Chairman, Alba Mineral Resources in the wake of the announcement of Final Results and the Greenland Spin-Out IPO

Zak Mir talks to Moni Borovitz, CEO MTI Wireless in the wake of the Group's financial performance over Q1 which translated into a 25% improvement in profit before tax. 

Zak Mir speaks with Paul Gazzard in the wake of the latest news regarding a Joint Venture Agreement in relation to flexibility power expert HSKB Ltd =of which Dukemount will acquire 50% of the issued share capital of HSKB for nominal value.   

Zak Mir is joined by Richard Lloyd from NR Private Market, as well as Anthony Brooke (Chairman) and Nick Marrett (CEO) from Gembridge. They run through Gembridge's online platform for coloured gemstones and the opportunity this niche market offers currently.

Zak Mir interviews Carleton Curtis, Executive Chairman, Guild Esports on the global launch of its Esports Acadamy to drive growth. 

Zak Mir is joined by regulars Albert Arthur, Phil Carroll and Kevin Hornsby for more stock market banter. Their guest this week is Dr Gareth Cave of Remote Monitored Systems (RMS) / Pharm2Farm

Podcast Minutes:

32s The Hot Tub

1m 18s  Dr Gareth Cave intro

2m 30s Gareth dons a white coat

2m 45s New branded boxes of masks

3m 15s Gareth’s mother in law

3m 41s Gareth’s jobs

4m 20s Gareth thanks shareholders

4m 50s Albert asks about Gareth’s working hours

5m 40s Phil asks about the Lemu machine

7m 27s Gareth on the relationship with Voltz

8m 10s Gareth on manufacturing

offers from around the world

8m 39s Gareth on the anti-viral layer

9m 40s Albert asks Gareth, have you gone global? The IP?

10m 14s Gareth on the a-virion

10m 57s Kevin on other products

11m 35s Gareth on air filtration

12m 35s Gareth on nano particles

14m 00s Albert on terminating viruses

14m 45s Gareth on COVID, flu viruses and man flu.

15m 25s Albert on the pandemic coming back

16m 05s Gareth on the pandemic - India

18m 02s Phil on the shark in the net

18m 28s Gareth on face mask biohazard and lobby NHS / Government

19m 35s Phil asks about the cost of copper nano particles and other metals

20m 50s Gareth on leachability / Cerium / cataracts

21m 44s Phil asks about Numed and distribution

23.17m  Gareth’s background

26m 15s Zak wakes up

26m 52s Is the Remote Monitored Systems (RMS) soap opera over?

27m 28s  Albert on RMS from investors / traders perspective

28m 20s Gareth on not cashing out / the business opportunity

29m 36s Kevin asks about mask sales

29m 52s  Gareth talks about helping people in India

30m 28s Albert and Kevin on people picking up used masks

31m 33s Gareth on pandemic profiteering

31m 50s Kevin asks on mask sales again

32m 11s Gareth on four goals

32m 46s  Kevin asks Gareth about the other parts of RMS

34m 00s Gareth on Gyrometrics

34m 44s Zak asks what the goal is at RMS / Pharm2farm?

36m 55s Zak asks Gareth about fresh changes at RMS and a new CEO

39m 03s Phil’s week on

39m 23s Forbes Ventures (FOR)

40m 29s Phil on Zak interviewing Supply@Me Capital (SYME)

40m 52s Zak on interviewing SYME

41m 18s Albert on Zak interviewing SYME

41m 34s Zak on SYME interviews

43m 16s  Phil on complex companies

43m 35s what the market is missing at SYME

43m 52s Zak on puff piece interviews

44m 24s Albert on getting Alessandro Zamboni on the Roast

44m 51s Phil on Oriole Resources (ORR)

46m 01s on Greatland Gold (GGP)

46m 58s Kevin’s week

47m 12s on RMS

47m 47s  ORR

48m 20m  Caerus (CMRS)

49m 00s Empyrean (EME)

50m 32s SYME

51m 08s Albert’s low carb diet / split hit / ketosis

52m 18m Albert’s stock review

52m 47s perpetual Covid loop

53m 35s Synairgen (SNG), Scancell (SCLP), Tiziana (TILS)

53m 52s Futura Medical (FUM)

54m 22s DeepVerge (DVRG)

57m 04s Velocity Composites (VEL)

58m 30s SNG as Novacyt (NCYT) II

58m 57s MyHealthChecked (MHC)

1h 01m 35s Musk and crypto

1h 02m 23s the return of the Covid bubble

1h 03m 03s Kevin on the fall of the coins

1h 03m 17s Albert on sentiment / fear

1h 05m 09s the yoga mat floor

1h 06m 25s Zak’s week on shorting targets

1n 06m 42s Tern (TERN)

1h 07m 04s Guild (GILD)

1h 07m 12s Cornish Metals (CUSN)

1h 07m 32s FTSE 100

1h 07m 49s Elon Musk

1h 07m 56s Phil on Musk

1h 09m 15s Zak on Bitcoin down / stock market up

1h 09m 44s Phil on coin dealing from £500,000 to £500

1h 10m 14s Zak on crypto volatility and leverage

Zak Talks to Neill Ricketts, CEO Versarien about progress at the advanced materials group, and how much the pandemic environment has enhanced and accelerated opportunities for the company.

Zak Mir talks to Andrew Newland, CEO Angle to discuss the implications of the failure of a major ovarian screening trial, and what his company can contribute to this area going forward.